Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance vs Observation in APL (S0521)
NCT00492856Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Jun 2007
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of tretinoin, mercaptopurine, methotrexate in acute promyelocytic leukemia (APL), sponsored by SWOG Cancer Research Network. Started Jun 2007; status: completed.
02
Drugs
tretinoinmercaptopurinemethotrexate
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT00492856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00492856.